Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Clinical trial NCT01276327 · COMPLETED
Trial details
- NCT number
- NCT01276327
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-05-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.